Kuwait Pharmaceuticals and Healthcare Report Q3 2012

Published : July 2012
No. of Pages : 93

Price:

BMI View: Kuwait is in the middle of a large infrastructure expansion project that will increase access to healthcare and opportunities for drugmakers and healthcare providers looking to take part in publicprivate partnerships (PPPs). However, the country still has some way to go in terms of legislating for a dynamic healthcare industry, and political stalemate is hindering progress.
Headline Expenditure Projections 􀂃 Pharmaceuticals: KWD204mn (US$737mn) in 2011 to KWD216mn (US$771mn) in 2012; +6.1% in local currency terms and +4.7% in US dollar terms. Forecast unchanged from Q212.
􀂃 Healthcare: KWD1.04bn (US$3.76bn) in 2011 to KWD1.11bn (US$3.98bn) in 2012; +7.3% in local currency terms and +5.9% in US dollar terms. Forecast and historic data down from Q212 owing to new data from the World Healthcare Organization (WHO).
􀂃 Medical devices: KWD75mn (US$273mn) in 2011 to KWD82mn (US$292mn) in 2012; +7.2% in local currency terms and +5.8% in US dollar terms. Forecast down from Q212.
Risk/Reward Rating: In BMI’s Pharmaceuticals Risk/Reward Ratings (RRRs) table for Q312, Kuwait has fallen back to second position. Its risks profile is stronger than its rewards, which are squeezed by the small market size and political instability that may stall the reform of its healthcare system. Although we don’t expect Kuwait to overtake the UAE again in the coming quarters, it will maintain a high position, reflective of the country’s high per-capita drug spend and urbanised country structure, which together offset the disadvantages that stem from the small overall size of the pharmaceutical sector.
Key Trends And Developments 􀂃 In February 2012, as part of a drive to improve healthcare for diabetes patients, Kuwait’s healthcare service announced that it is partnering with a UK-based health trust to learn how to implement an electronic patient records system. Like Kuwait, the Tayside area of Scotland has a high prevalence of diabetes, making the authority suited to passing on lessons in diabetic patient management.
􀂃 In May 2012, local news sources in Kuwait reported that drug prices in the country remain prohibitively high and vary between retail outlets. There have been calls for the government to implement more price screening measures to ensure retail outlets are sticking to agreed pricing levels. Controller of the national assembly, Mohammad al-Duwailah, has called for greater vigilance in monitoring the prices of medicines.
􀂃 The health ministry announced in May 2012 that it would approve a new mechanism to control the cost of medical services in private hospitals and clinics through the Medical Licensing Division so as to protect patients who visit such medical centres. The need for such a system has arisen as patients have complained about prohibitively high healthcare prices. This healthcare inflation can be seen in Kuwait’s consumer price inflation (CPI) basket as the cost of hospital services has increased by more than 160% since 2000 when the index was created
BMI Economic View: We expect the Kuwaiti economy to continue growing robustly in 2012. Elevated global hydrocarbon prices will allow the government to keep fiscal spending high, driving domestic consumption, while oil production looks set to remain near capacity in the months ahead. While our outlook on fixed investment is less positive, we forecast real GDP growth of 4.5% in 2012, down only modestly on estimated growth of 5.7% last year.
BMI Political View: The failure of negotiations between the Kuwaiti emir and opposition MPs for the latter to participate in the new cabinet will weigh on the country’s near-term political outlook. Further delays to the implementation of the government’s spending plans now appear likely. As a result, we have revised down our short-term political risk rating, as well as a number of our economic forecasts for 2012.

Executive Summary ... 6
SWOT Analysis 8
Kuwait Pharmaceuticals And Healthcare Industry SWOT ... 8
Kuwait Political SWOT .. 9
Kuwait Economic SWOT 9
Kuwait Business Environment SWOT .. 10
Pharmaceutical Risk/Reward Ratings . 11
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q312 .. 12
Rewards ... 16
Risks ... 17
Kuwait – Market Summary 18
Regulatory Regime .. 19
Foreign Direct Investment Regulations 20
Intellectual Property Regime . 20
IP Shortcomings . 21
Pricing Regime .. 21
Reimbursement Regime 23
Public Procurement Of Medicines ... 24
Regional Harmonisation .. 24
Free Trade Agreements 26
Industry Developments . 27
Epidemiology . 27
Communicable Diseases .. 28
Non-Communicable Diseases 29
Healthcare Sector .. 30
Healthcare Sector Reform 31
Healthcare Staff . 33
Primary Care . 34
Secondary Care.. 34
Public Health Developments .. 35
Healthcare Financing .. 36
Healthcare Insurance ... 37
Healthcare Insurance Developments ... 38
Research & Development . 38
Biotechnology Sector ... 39
Clinical Trials 40
Medical Devices . 40
Table: New Products Launched In 2009 41
Industry Forecast Scenario .. 42
Overall Market Forecast .. 42
Table: Pharmaceutical Sales Indicators 2008-2016 43
Key Growth Factors – Industry .. 44
Table: Healthcare Expenditure Indicators 2008-2016 .. 45
Table: Healthcare Governmental Indicators 2008-2016... 46
Table: Healthcare Private Indicators 2008-2016 46
Macroeconomic Forecast 47
Table: Kuwait Economic Activity, 2011-2016 52
Prescription Drug Market Forecast . 53
Table: Prescription Drug Sales Indicators 2008-2016 .. 54
Patented Drug Market Forecast 55
Table: Patented Drug Market Indicators 2008-2016 . 56
Generic Drug Market Forecast .. 57
Table: Generic Drug Sales Indicators 2008-2016 ... 58
OTC Medicine Market Forecast 59
Table: OTC Medicine Sales Indicators 2008-2016 .. 60
Pharmaceutical Trade Forecast . 61
Table: Exports And Imports Indicators 2008-2016 .. 63
Medical Device Market Forecast . 64
Table: Medical Devices Sales Indicators 2008-2016 . 65
Other Healthcare Data 66
Key Risks To BMI Forecasts .. 67
Competitive Landscape 68
Pharmaceutical Industry .. 68
Regional Pharmaceutical Sector Developments... 68
Foreign Company Developments . 70
Pharmaceutical Distribution .. 70
Company Profiles 71
Local Companies 71
Kuwait-Saudi Pharmaceutical Industries (KSP) .. 71
Advanced Technology Company 72
Bader Sultan & Bros 74
Safwan Trading And Contracting Company .. 76
Multinationals ... 78
Novartis ... 78
Sanofi . 79
Pfizer.. 80
GlaxoSmithKline 81
Merck & Co . 82
Johnson & Johnson 83
Demographic Outlook . 85
Table: Population By Age Group, 1990-2020 (‘000) . 86
Table: Population By Age Group, 1990-2020 (% of total) 87
Table: Key Population Ratios, 1990-2020 . 88
Glossary ... 89
BMI Methodology . 91
How We Generate Our Pharmaceutical Industry Forecasts ... 91
Pharmaceuticals Risk / Reward Ratings . 92
Risk/Reward Ratings Methodology . 92
Ratings Overview 92
Table: Pharmaceutical Risk/Reward Indicators .. 93
Weighting . 94
Table: Weighting Of Components 94Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q312 . 12

Table: New Products Launched In 2009 . 41

Table: Pharmaceutical Sales Indicators 2008-2016 . 43

Table: Healthcare Expenditure Indicators 2008-2016 . 45

Table: Healthcare Governmental Indicators 2008-2016. 46

Table: Healthcare Private Indicators 2008-2016 . 46

Table: Kuwait Economic Activity, 2011-2016 . 52

Table: Prescription Drug Sales Indicators 2008-2016 . 54

Table: Patented Drug Market Indicators 2008-2016 . 56

Table: Generic Drug Sales Indicators 2008-2016 . 58

Table: OTC Medicine Sales Indicators 2008-2016 . 60

Table: Exports And Imports Indicators 2008-2016 . 63

Table: Medical Devices Sales Indicators 2008-2016 . 65

Table: Population By Age Group, 1990-2020 (‘000) . 86

Table: Population By Age Group, 1990-2020 (% of total) . 87

Table: Key Population Ratios, 1990-2020 . 88

Table: Pharmaceutical Risk/Reward Indicators . 93

Table: Weighting Of Components . 94

Kuwait Pharmaceuticals and Healthcare Report Q3 2012

Published By: Business Monitor International

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: